Dr. Duncan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# 4
Pittsburgh, PA 15213Phone+1 412-648-6161
Education & Training
- UPMC Medical EducationResidency, 1984 - 1985
- University of Washington School of MedicineResidency, 1981 - 1984
- University of Washington School of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1985 - Present
- AL State Medical License 2015 - 2025
- PA State Medical License 1984 - 2024
- WA State Medical License 1982 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis Start of enrollment: 2018 Sep 04
Roles: Contact, Principal Investigator
- GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis Start of enrollment: 2020 Sep 07
Roles: Principal Investigator, Contact
- Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis Start of enrollment: 2023 Oct 01
Roles: Contact
Publications & Presentations
PubMed
- Anti-Heat Shock Protein 70 Autoantibodies from Patients with Idiopathic Pulmonary Fibrosis Epigenetically Enhance Lung Fibroblast Apoptosis Resistance and Bcl-2 Expres...Baiyun Zhong, Jennifer Q Zhou, Xing Lyu, Hui Liu, Kayu Yuan
Journal of Immunology. 2024-10-15 - 3 citationsDesign of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand
BMC Pulmonary Medicine. 2024-03-20 - Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, Ivan O Rosas, Mary Beth Scholand
Research Square. 2024-02-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: